Page 23 - Lab Studies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Covid-19. this is phase two and three clinical study data that shows the pill is like earlier studies show, it's 89% effective at keeping high risk people who catch covid-19 alive and out of the hospital. more than 2,000 unvaccinated study participants, no one that received the anti-viral pill died. and you do need people to get this pill pretty soon after they start having symptoms. if you take the pill within five days instead of three days, the pill's effectiveness starts to drop. but it is still up in the high 80s in terms of the percentage reduction in people needing to be hospitalized. p...

Public. joining me now is dr. uché blackstock. she's the founder and ceo of advancing health equity and an msnbc contributor. i read that about director rochelle wolensky about the omicron variant. can you explain what she means when she says the booster helps boost the efficacy against omicron? >> right. thanks so much for having me on this evening, zerlina. we don't have tons of data. this is all based on preliminary data, and most of it is based on lab studies. and essentially what we see is when you mix essentially the blood of people who are vaccinated versus people who are unvaccinated,...

Well those vaccines work in the fight against the virus. today pfizer announced that their own preliminary lab studies show their booster shot provides strong protection against the new omicron variant. we should be clear, this data has not yet been peer reviewed and they're announcing it, so it's by no means a complete picture, it's going to require further scrutiny by health agencies. even so, this announcement has left a lot of people feeling optimistic about the new variant, including dr. anthony fauci. >> the pfizer data now gives us very important information that although there's diminu...

Covid-19 deaths by 90%. so that reinforces what pfizer reported from their preliminary lab studies, which showed three doses of their vaccine can neutralized omicron variant. joining us now is dr. william schaffner, professor in the division of infectious diseases at vanderbilt university medical center. doctor the latest numbers show a quarter of vaks nccinated adult have gotten a booster shot. why do you think that number is so low right now. these are people already fully vaccinated. >> there's vaccine fatigue out there, ana, i'm afraid. but these new data that you've just referenced, i hop...

Many mutations. but pfizer has done a study in their labs that finds that the vaccine does work to a great extent. now, it did take a hit. the variant is tough and it did manage to outsmart the vaccine to some extent, but still, two doses are effective in many ways, and three doses are even better. and pfizer's news, well, this actually seems to jive with what researchers in south africa found when they did their own lab studies. so let's take a look at what these studies show. these studies, which are in a lab and are preliminary suggest that two doses may not provide sufficient protection ag...